ImmuCell Corp banner

ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 6.61 USD 2.64% Market Closed
Market Cap: $59.8m

ImmuCell Corp
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ImmuCell Corp
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
ImmuCell Corp
NASDAQ:ICCC
Other Items
$31.1k
CAGR 3-Years
46%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Items
-$5.4B
CAGR 3-Years
N/A
CAGR 5-Years
32%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Other Items
-$4.2B
CAGR 3-Years
-35%
CAGR 5-Years
21%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Other Items
-$85m
CAGR 3-Years
74%
CAGR 5-Years
55%
CAGR 10-Years
33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Items
-$507.8m
CAGR 3-Years
-63%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Items
$584.6m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

ImmuCell Corp
Glance View

Market Cap
59.8m USD
Industry
Biotechnology

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

ICCC Intrinsic Value
4.78 USD
Overvaluation 28%
Intrinsic Value
Price $6.61

See Also

What is ImmuCell Corp's Other Items?
Other Items
31.1k USD

Based on the financial report for Dec 31, 2025, ImmuCell Corp's Other Items amounts to 31.1k USD.

What is ImmuCell Corp's Other Items growth rate?
Other Items CAGR 5Y
-54%

Over the last year, the Other Items growth was 591%. The average annual Other Items growth rates for ImmuCell Corp have been 46% over the past three years , -54% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett